Edwards Lifesciences Corporation (EW)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 42.12B |
| Enterprise value | 41.29B |
| Trailing P/E | 30.65 |
| Forward P/E | 24.63 |
| PEG ratio (5-yr expected) | 4.08 |
| Price/sales (ttm) | 7.54 |
| Price/book (mrq) | 6.61 |
| Enterprise value/revenue | 7.30 |
| Enterprise value/EBITDA | 21.49 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.03 |
| 52-week change 3 | -18.93% |
| S&P500 52-week change 3 | 16.57% |
| 52-week high 3 | 94.87 |
| 52-week low 3 | 67.13 |
| 50-day moving average 3 | 77.34 |
| 200-day moving average 3 | 81.45 |
Share statistics
| Avg vol (3-month) 3 | 3.31M |
| Avg vol (10-day) 3 | 3.56M |
| Shares outstanding 5 | 607.92M |
| Implied shares outstanding 6 | 607.92M |
| Float 8 | 602.29M |
| % held by insiders 1 | 0.85% |
| % held by institutions 1 | 85.59% |
| Shares short (14 Sept 2023) 4 | 12.7M |
| Short ratio (14 Sept 2023) 4 | 3.91 |
| Short % of float (14 Sept 2023) 4 | 2.11% |
| Short % of shares outstanding (14 Sept 2023) 4 | 2.09% |
| Shares short (prior month 14 Aug 2023) 4 | 9.51M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 3:1 |
| Last split date 3 | 31 May 2020 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2022 |
| Most-recent quarter (mrq) | 29 Jun 2023 |
Profitability
| Profit margin | 24.56% |
| Operating margin (ttm) | 28.44% |
Management effectiveness
| Return on assets (ttm) | 11.54% |
| Return on equity (ttm) | 22.40% |
Income statement
| Revenue (ttm) | 5.66B |
| Revenue per share (ttm) | 9.25 |
| Quarterly revenue growth (yoy) | 11.40% |
| Gross profit (ttm) | 4.3B |
| EBITDA | 1.75B |
| Net income avi to common (ttm) | 1.39B |
| Diluted EPS (ttm) | 2.23 |
| Quarterly earnings growth (yoy) | -24.40% |
Balance sheet
| Total cash (mrq) | 1.51B |
| Total cash per share (mrq) | 2.48 |
| Total debt (mrq) | 684.5M |
| Total debt/equity (mrq) | 10.62% |
| Current ratio (mrq) | 3.15 |
| Book value per share (mrq) | 10.49 |
Cash flow statement
| Operating cash flow (ttm) | 940.4M |
| Levered free cash flow (ttm) | 808.52M |
© 2023 Yahoo. All rights reserved.
